EMEA-001368-PIP01-12
Key facts
| Active substance |
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0175/2013
|
| PIP number |
EMEA-001368-PIP01-12
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
AbbVie Ltd
United Kingdom |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|